Hims & Hers Health (NYSE:HIMS – Get Free Report) released its quarterly earnings results on Monday. The company reported $0.06 earnings per share for the quarter, beating the consensus estimate of $0.05 by $0.01, Briefing.com reports. Hims & Hers Health had a negative return on equity of 0.70% and a negative net margin of 0.24%. The company had revenue of $315.65 million for the quarter, compared to analyst estimates of $302.43 million. During the same period in the previous year, the company posted ($0.03) earnings per share. The firm’s revenue was up 51.8% on a year-over-year basis.
Hims & Hers Health Stock Performance
Shares of NYSE:HIMS traded down $0.69 during midday trading on Tuesday, reaching $17.15. 11,352,575 shares of the company’s stock traded hands, compared to its average volume of 7,732,266. The company has a market cap of $3.68 billion, a price-to-earnings ratio of -1,628.00 and a beta of 1.08. Hims & Hers Health has a one year low of $5.65 and a one year high of $25.74. The stock has a 50 day moving average of $21.39 and a 200 day moving average of $15.80.
Insider Activity at Hims & Hers Health
In related news, CEO Andrew Dudum sold 188,888 shares of the company’s stock in a transaction on Tuesday, June 4th. The stock was sold at an average price of $19.88, for a total transaction of $3,755,093.44. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, CEO Andrew Dudum sold 188,888 shares of the company’s stock in a transaction on Tuesday, June 4th. The stock was sold at an average price of $19.88, for a total transaction of $3,755,093.44. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Michael Chi sold 7,500 shares of the company’s stock in a transaction on Thursday, June 20th. The shares were sold at an average price of $24.50, for a total value of $183,750.00. Following the sale, the insider now owns 185,326 shares of the company’s stock, valued at approximately $4,540,487. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 782,901 shares of company stock worth $16,138,997. 17.71% of the stock is owned by insiders.
Analyst Ratings Changes
Get Our Latest Research Report on HIMS
About Hims & Hers Health
Hims & Hers Health, Inc operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.
Featured Articles
- Five stocks we like better than Hims & Hers Health
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Uber’s Earnings Beat: Rideshare and Delivery Surge
- Why is the Ex-Dividend Date Significant to Investors?
- Hims & Hers Reports Stellar Quarter: Stock Set for a Rally
- How to invest in marijuana stocks in 7 stepsĀ
- Cloudflare Stock Flares Up on Solid EPS Beat and Raised Guidance
Receive News & Ratings for Hims & Hers Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hims & Hers Health and related companies with MarketBeat.com's FREE daily email newsletter.